Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Pritesh Topiwala

Anesthesiology Boston, MA Medical Doctor

NPI 1386057214 CMS profile 5218266

75 Francis St, Boston, MA 02115

Open in the dashboard

General payments

$30,031

236 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Pritesh Topiwala of Boston, MA is reported in the CMS Open Payments database as having received $30,031 across 236 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Anesthesiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,937 17
2024 General $9,798 31
2023 General $5,520 49
2022 General $1,412 31
2021 General $6,461 62
2020 General $410 10
2019 General $3,493 36

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Pritesh Topiwala
  • Anesthesiology median
  • Middle half of Anesthesiology
  • National median

In program year 2025, general payments to Pritesh Topiwala were reported at $2,937. Among 18,548 Anesthesiology profiles paid that year, the median was $58 and the middle half received between $26 and $153.

Show as a table
Year Pritesh Topiwala Anesthesiology median Middle half National median
2019 $3,493 $72 $23–$151 $163
2020 $410 $36 $17–$120 $114
2021 $6,461 $49 $21–$135 $132
2022 $1,412 $52 $22–$144 $149
2023 $5,520 $53 $23–$143 $160
2024 $9,798 $55 $25–$150 $164
2025 $2,937 $58 $26–$153 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $19,735 111 payments
  2. Boston Scientific Corporation $3,574 47 payments
  3. Medtronic USA, Inc. $2,143 30 payments
  4. MML US, Inc. $2,138 21 payments
  5. Abbott Laboratories $1,152 11 payments
  6. Saluda Medical Americas, Inc. $378 2 payments
  7. Vertos Medical, Inc. $356 3 payments
  8. Nevro Corp. $315 6 payments
  9. SPR Therapeutics, Inc $175 2 payments
  10. Relievant Medsystems, Inc. $49 2 payments
  11. Other $15 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $13,230 6 payments
  2. Food and Beverage $9,860 195 payments
  3. Travel and Lodging $6,459 33 payments
  4. Education $483 2 payments
Products named General payments · program years 2019–2025
  1. INTELLIS ADAPTIVESTIM $14,793 49 payments
  2. ReActiv8 $2,138 21 payments
  3. SYNCHROMEDII $1,794 18 payments
  4. Vanta $1,646 11 payments
  5. WAVEWRITER ALPHA $1,372 9 payments
  6. RESTORE $1,175 8 payments
  7. WaveWriter Alpha Prime 16 $1,055 16 payments
  8. SYNCHROMED $799 9 payments
  9. Axium INS DRG IPG $665 3 payments
  10. INTELLIS $461 16 payments
  11. Other $4,196 79 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 15 drugs

Part D claims

507

Median for Anesthesiology: 322

Drug cost

$11,810

Median for Anesthesiology: $8,738

Branded share of claims

2.2%

Median for Anesthesiology: 25.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Buprenorphine Generic 30 $4,452
Pregabalin Generic 57 $2,441
Gabapentin Generic 106 $1,217
Tizanidine Hcl Generic 61 $1,093
Oxycodone Hcl Generic 62 $880
Duloxetine Hcl Generic 13 $338
Diclofenac Sodium Generic 31 $335
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 11 $252
Baclofen Generic 12 $213
Hydromorphone Hcl Generic 13 $152

The 10 drugs with the highest cost, of 15 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,517 Part D prescribers listed as Anesthesiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 95 billing codes

Paid by Medicare

$64,492

Medicare's payments for the services billed

Medicare patients

297

Average age 73

Services billed

786

164 women, 133 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Depression 37%
Ischemic heart disease 36%
Diabetes 34%
Chronic kidney disease 30%
Atrial fibrillation 26%
Cancer 26%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

236 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Anesthesiology in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record